430
Participants
Start Date
December 15, 2015
Primary Completion Date
August 30, 2016
Study Completion Date
August 1, 2017
GSK Biologicals Herpes Zoster subunit (HZ/su) vaccine (GSK 1437173A)
2 doses administered by intramuscular (IM) injection into the deltoid muscle of the non-dominant arm.
GSK Investigational Site, Endwell
GSK Investigational Site, Binghamton
GSK Investigational Site, Uniontown
GSK Investigational Site, Erie
GSK Investigational Site, Erie
GSK Investigational Site, Philadelphia
GSK Investigational Site, Columbia
GSK Investigational Site, Elkridge
GSK Investigational Site, Newport News
GSK Investigational Site, Charlotte
GSK Investigational Site, Spartanburg
GSK Investigational Site, Mt. Pleasant
GSK Investigational Site, Huntsville
GSK Investigational Site, Cleveland
GSK Investigational Site, Marshfield
GSK Investigational Site, Eau Claire
GSK Investigational Site, Lenexa
GSK Investigational Site, Newton
GSK Investigational Site, Wichita
GSK Investigational Site, Boise
GSK Investigational Site, Layton
GSK Investigational Site, South Jordan
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Daly City
GSK Investigational Site, Oakland
GSK Investigational Site, Los Gatos
GSK Investigational Site, Santa Rosa
GSK Investigational Site, Roseville
GSK Investigational Site, Corvallis
GSK Investigational Site, Auburn
GSK Investigational Site, Marlborough
Lead Sponsor
GlaxoSmithKline
INDUSTRY